Superior Determination of HPV using RNAscope™ In Situ Hybridization
contributed by Bio-Techne |
HPV has been identified as a causal agent in oropharyngeal squamous cell carcinoma (OPSCC) with the incidence of HPV-related OPSCC increasing dramatically over the last several decades. As patients with HPV-positive OPSCC have a significantly better survival compared to patients with HPV-negative OPSCC, testing for HPV status is critical.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!